PATENT CLAIM ANALYSIS

Application Number: 15574769
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2018-05
Patent Classification: ["514", "339000"]

Abstract:
Described herein are methods and compositions for the treatment of conditions, diseases, or disorders associated with autotaxin activity. The methods and compositions disclosed herein include the use of at least one autotaxin inhibitor compound.

Claim (Index 31):
The method of any one of  claims 28 - 30 , wherein the inflammatory disease or condition, or an autoimmune disease or condition is psoriasis, rheumatoid arthritis, vasculitis, inflammatory bowel disease, dermatitis, osteoarthritis, asthma, inflammatory muscle disease, allergic rhinitis, vaginitis, interstitial cystitis, scleroderma, eczema, lupus erythematosus, dermatomyositis, Sjogren's syndrome, thyroiditis, myasthenia gravis, autoimmune hemolytic anemia, multiple sclerosis, cystic fibrosis, chronic relapsing hepatitis, primary biliary cirrhosis, primary sclerosing cholangitis, allergic conjunctivitis or atopic dermatitis.

Metadata:
- Claim Count in Document: 32.0
- Percentile: 91.0
- Lexical Diversity: 1.31034
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14628970', '13439495', '15539088', '15060398', '15022180']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7883551416245512
- 35 USC 102 Novelty (BERT): 0.5153407062527837
- Combined Prediction Score: 0.7610536980873744
- Mean Citation Score: 276.17016
- Max Citation Score: 305.50748
- Similarity Product: 234.3549628373241

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test